GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (STU:AGT) » Definitions » EV-to-EBITDA

AptarGroup (STU:AGT) EV-to-EBITDA : 15.28 (As of May. 19, 2024)


View and export this data going back to 2013. Start your Free Trial

What is AptarGroup EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AptarGroup's enterprise value is €9,886 Mil. AptarGroup's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €647 Mil. Therefore, AptarGroup's EV-to-EBITDA for today is 15.28.

The historical rank and industry rank for AptarGroup's EV-to-EBITDA or its related term are showing as below:

STU:AGT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.9   Med: 13.43   Max: 20.28
Current: 15.35

During the past 13 years, the highest EV-to-EBITDA of AptarGroup was 20.28. The lowest was 8.90. And the median was 13.43.

STU:AGT's EV-to-EBITDA is ranked better than
51.64% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.155 vs STU:AGT: 15.35

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-19), AptarGroup's stock price is €135.60. AptarGroup's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €4.311. Therefore, AptarGroup's PE Ratio for today is 31.45.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


AptarGroup EV-to-EBITDA Historical Data

The historical data trend for AptarGroup's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup EV-to-EBITDA Chart

AptarGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.66 17.71 15.61 13.56 13.74

AptarGroup Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.80 14.12 14.29 13.74 15.00

Competitive Comparison of AptarGroup's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, AptarGroup's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AptarGroup's EV-to-EBITDA falls into.



AptarGroup EV-to-EBITDA Calculation

AptarGroup's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9885.903/647.117
=15.28

AptarGroup's current Enterprise Value is €9,886 Mil.
AptarGroup's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €647 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AptarGroup  (STU:AGT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AptarGroup's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=135.60/4.311
=31.45

AptarGroup's share price for today is €135.60.
AptarGroup's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.311.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


AptarGroup EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AptarGroup's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup (STU:AGT) Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

AptarGroup (STU:AGT) Headlines